搜索到 1000 条关于 y66문발해커디비판매|l텔레그램popkonDB* 的文章

2018.04.28 如何降低并应对实验室 OOS 的发生?— 6 月金牌课程为您答疑解难

)及趋势偏差(OOT)拜耳/江苏恒瑞/天士力/山东绿叶等企业持续输送人员参与的原因:lOOS 实验结果的调查是一个集中的课程,涵盖 FDA 和美国药典 (USP)<1010> 英国药品和健康产品管理局 (MHPR) 和欧洲 OOS 指导原则草案。l 课程将深入
2014 欧洲低钠血症诊疗临床实践指南解读

2017.03.30 2014 欧洲低钠血症诊疗临床实践指南解读

低钠血症的定义为血清钠低于 135 mmol / L,为临床最常见的水盐失衡类型,其发生率约占住院患者的 30% ,因其涉及临床学科较广而备受临床医生的关注...可能降低 4 ~5 mmol/L。2. 非低渗性低钠血症血清含有其他渗透性物质使有效渗透压增加,吸引细胞内的水至细胞外液而导致细胞外液稀释所致低钠血症。3.

2011.11.03 女性,进食差10余天,呕吐4天,严重低钠血症一例

:106mmol/L,氯80mmol/L,钾正常,查腹部超声肝、胆胰脾正常,胸片正常;心电图心肌缺血,肝功能、肾功能正常,心肌酶正常;凝血分析正常;血尿淀粉酶正常;既往心力衰竭...少,呕吐减轻,复查血钠仍在110mmol/L左右,血钾下降2.76mmol/L。现患者进食少,嗜睡,尿量2000ml,请问下一步治疗,目前诊断?考虑进食差引起的严重
叶酸和维生素B12不能改善老年人认知功能

2014.12.25 叶酸和维生素B12不能改善老年人认知功能

近日,来自美国的Nikita L. van der Zwaluw等人报道了一项研究,在高同型半胱氨酸(Hcy)水平的老年人中,对其进行为期2年的叶酸和维生素...纳入了包括2919名老年人研究对象,年龄都在65岁或以上,其Hcy水平都在12和50µmol/L之间,所有的参与者每天会收到相应的药片,实验组将每天收到400
腰椎单节段融合椎弓根螺钉的位置明显影响上方邻近节段的生物力学

2012.01.05 腰椎单节段融合椎弓根螺钉的位置明显影响上方邻近节段的生物力学

效应,该研究结果最近发表在Spine杂志上。在该研究中,作者基于L4-5腰椎融合手术中椎弓根螺钉在L4椎体上的位置,模拟出4个L4-5融合模型,包括代表椎弓根螺钉植入导致的双侧L3/4关节突关节破坏状态的FV模型、代表椎弓根螺钉对双侧L3/上关节突关节均无侵犯(non-encroachment)状态的FP模型

2012.09.19 2012第三届最新生物技术与仪器研讨会

,为研发成果的市场转化和临床应用提供更大的空间。CIB2012热点话题主要包括:l临床分子病理与人组织标本库;l分子免疫与标记示踪;l干细胞纯化和应用;l临床生物信息学与生物靶标;l生物技术与转化医学
HIV 感染者感染结核杆菌后应何时启动抗病毒治疗?

2014.09.07 HIV 感染者感染结核杆菌后应何时启动抗病毒治疗?

。来自坦桑尼亚的研究人员通过研究 HIV 阳性且 CD4 细胞计数 ≥ 220/µL 患者感染 TB 后开始 ART 治疗的时间,来寻找其与结核治疗结果的相关性。研究发现,对于 HIV 阳性且 CD4 细胞计数大于 220/µL 的结核患者,ART 治疗可以延迟到 6 个月的抗结核治疗结束后进行。该文章发表在 2014 年
腔镜下胃减容术和 Roux-en-Y 吻合术各有利弊

2015.10.26 腔镜下胃减容术和 Roux-en-Y 吻合术各有利弊

近期和远期的并发症。腹腔镜下 Roux-en-Y 吻合术(Roux-en-Ygastricbypass,RYGB)和腹腔镜
Spine最新研究证实椎间盘源性腹股沟区疼痛的存在

2012.01.30 Spine最新研究证实椎间盘源性腹股沟区疼痛的存在

近期,有动物实验研究发现,单节段椎间盘的感觉神经末梢可以与多节段背根神经(DRGs)相关,对于小鼠来说,L5-6椎间盘的神经纤维可能与上位背根神经发生联系。以此推论,因为人类腹股沟区感觉由L1或L2脊神经终支——生殖股神经和髂腹股沟神经支配,故腹股沟区疼痛也可能是与间盘因素相关的牵涉痛

2012.09.19 2nd Asia-Pacific Osteoporosis and Bone Meeting

会议简介 WelcomeThe Presidents of IOF and ANZBMS along with the Local Organising Committee are pleased to invite you to participate in the IOF Regionals - 2nd Asia-Pacific Osteoporosis and Bone Meeting being held in conjunction with the ANZBMS Annual Scientific Meeting and JSBMR in September 4-8, 2011.The Asia-Pacific region is the largest growth market in the world in the bone field. As revealed by the IOF Asian Audit in 2009, it is anticipated that by 2050 more than 50% of all osteoporotic fractures will occur in Asia.With an active Asia-Pacific Office and 28 member societies from the Region,? IOF Regionals provide the first and only? annual opportunity for a truly Regional Meeting to occur in the Asia-Pacific Region.? IOF Meetings focus on clinical treatment of osteoporosis as well as cutting edge science in the field. ANZBMS meetings are the peak Bone and Mineral professional events in the Australian and New Zealand region and JSBMR serves the entire Japanese community with annual scientific meetings in the area of bone and mineral research.The Meeting format includes plenary sessions, abstract presentations, poster presentations and viewing, Meet-the-Expert sessions, satellite symposia, award presentations, workshops and several social events.We hope to see you there!John A. Kanis,
President - International Osteoporosis FoundationRebecca Mason,
President - Australian and New Zealand Bone & Mineral Society
Program ? ?
Please see below for a draft program at a glance and preliminary seminar topics and associated titles. Please keep posted for more program details.PROGRAM AT A GLANCE - Please click here for a downloadable program at a glanceSEMINAR TOPICS
  • Biomechanics and Bone Measurement
  • Mark Forwood , "Why bones fail: structure and mechanics"
  • Ego Seeman , "Measuring microarchitecture"
  • Clinical Management of Osteoporosis I
  • Hiroshi Hagino , "Incidence and prevention of second hip fracture in Japan"
  • John Kanis , "To BMD or not to BMD?
  • Markus Seibel , "Fracture liaison services"
  • Clinical Osteoporosis Management II
  • Jacqui Center , "Osteoporosis Management and Mortality"
  • Toshio Matsumoto , "New strategies for treatment of osteoporosis"
  • Philip Sambrook , "Osteoporosis:? what should we measure, what should we check, whom should we treat, and with what?"
  • Fracture Risk Algorithms: Soothsaying or Science?
  • Emma Duncan , "Genetics, bones and fracture"
  • John Kanis , Getting to Grips with FRAX: how it really works
  • Male Osteoporosis
  • Shigeaki Kato , "Estrogens, androgens and bone"
  • Eric Orwoll , "Osteoporosis in men"
  • Malignancy and Bone
  • Cory Xian , "Mechanisms and prevention for cancer chemotherapy-induced bone defects"
  • Toshio Yoneda , "Bone pain associated with cancer metastasis to bone"
  • Andrew Zannetino , "Myeloma and bone"
  • Non-Canonical Bone
  • Paul Baldock , "Bones and brains"
  • Caryl Nowson , "Bones and salt: the renin/angiotensin/aldosterone axis in bone"
  • Matthew Warman , "LRP5, serotonin and bone"
  • Osteoclasts
  • Natalie Sims , "Osteoblastic support of osteoclasts"
  • Nao Takahashi , "Quiescent osteoclast precursors"
  • Sanuo Takeshita , "Couplin"
  • Sakae Tanaka , "Regulation of activity and apoptosis of osteoclasts"
  • Osteoporosis in Oceania / Asia Pacific Region
  • Cyrus Cooper, "Secular trends in fracture incidence: Why are fractures increasing in Asia but falling in the West?"
  • Edith Lau , "Strategies for fracture prevention in Asia - where do we go from here?"
  • Ambrish Mithal , "Strategies to overcome epidemic of Vitamin D deficiency in Asia"
  • Paediatric Bone Disease
  • Christopher Cowell , "Measuring a growing skeleton, and the effect of ethnicity on bone and body composition"?
  • Keiichi Ozono , "Osteoporosis and Osteopetrosis in the young"
  • Tania Winzenberg , "Nutrition and bone in children"
  • Paget''s Disease
  • Tim Cundy , "The epidemiology of Paget''s disease"
  • Stuart Ralston , "The genetics of Paget''s disease"
  • Rheumatology and Bone
  • Steven Goldring , "Inflammation and bone resorption in Rheumatoid Arthritis"
  • Hiroshi Takayanagi , "Osteoimmunology"
  • Gethin Thomas , "Inflammation and bone formation in Ankylosing Spondylitis"
  • Skeletal Dysplasias
  • Seiji Fukumoto , "Hypophosphataemia and FGF23"
  • Matthew Warman , "Mouse models for Skeletal Dysplasias"
  • Andreas Zankl , "Skeletal dysplasias: a new approach"
  • The Effects of Ageing
  • Neil Binkley , "Sarcopaenia and ageing"
  • David Scott , "Sarcopaenia and Vitamin D"
  • Therapeutics in Osteoporosis: Controversies
  • Peter Ebeling , "The perils and pitfalls of antiresorptives"
  • Satoshi Mori , "Fracture healing- tissue changes with bisphosphonates"
  • Alvin Ng , "Atypical Subtrochanteric and Diaphyseal Femoral Fractures - What We Know and What We Don''t"
  • Speaker to be confirmed , "The positives of bisphosphonates"
  • Workshop on Bone Regeneration
  • Simon Cool , "Stem cells and fracture repair"
  • Yunfeng Lin , "Adipose Stem Cells and Craniofacial Regeneration"
  • Hala Zreiqat , "A basis for building bone:? novel nanocomposite scaffolds for new bone growth"
Lung cancer:四川大学华西医院肿瘤胸部肿瘤学系王永生教授等报道肺腺癌向小细胞肺癌转化一例

2013.05.27 Lung cancer:四川大学华西医院肿瘤胸部肿瘤学系王永生教授等报道肺腺癌向小细胞肺癌转化一例

个月后,自觉腰部和右季肋区疼痛。复查胸部和腹部CT显示L1椎旁肿块,右侧L1腰椎和第九肋骨质破坏。根据手术标本检测EGFR基因发现19号外显子缺失。然而,口服埃

2011.10.28 老年女性,60岁,乳腺癌术后胸壁复发一例

病史特点:老年女性,60岁左右吧,右乳癌术后胸壁复发的。病理:浸润性导管癌。ER(+)PR(-)HER-2(-),P53(+)。现患者右侧胸壁多处破溃及大小多处结节。PET-CT示胸壁复发及多发骨转移(L2-L5及双侧髋关节)。心脏装有起搏器。因肾功不全3期未行双磷酸盐治疗及全身化疗,卡式评分:70

2024.09.10 影像组学研究思路和中标统计

来源:青椒医学影像组学是一个新兴领域,它通过获取多个定量图像特征将医学图像转换为可挖掘的数据。一、什么是影像组学「Radiomics」最早是由荷兰的学者 Philippe L...
领星携手中山一院金华伟教授团队探索中枢神经系统罗道病!

2021.12.07 领星携手中山一院金华伟教授团队探索中枢神经系统罗道病!

近日,领星与中山大学第一附属医院神经外科金华伟教授团队合作撰写的学术论文「Rosai-Dorfman disease in the central nervous system with two isolated l...

2019.09.09 2019 新《药品管理法》实施解读 -上海 10 月

2019年8月26日上午,新修订的《中华人民共和国药品管理法》经十三届全国人大常委会第十二次会议表决通过,将于2019年12月1日起施行。修订后的药品管理法共十二章155条,加大了对药品违法行为的处罚力度。新《药品管理法》,给药企带来了诸多变化:l药品的定义发生了变化;l假药、劣药的范围发生了变化;l未来药品上市许可持有人、药品生产经营企业等各主体的责任如何界定;l药品追溯体系如何建立……《药品管理法》是我国药品监管 ...
精彩幻灯:复发和依赖肾病综合征诊治循证指南

2017.01.18 精彩幻灯:复发和依赖肾病综合征诊治循证指南

肾病综合征诊断标准大量蛋白尿,低蛋白血症, 高脂血症:血总胆固醇>5.7mmol/L, 不同程度的水肿。
质子泵抑制剂治疗或无益于降低 COPD 急性加重风险

2016.08.20 质子泵抑制剂治疗或无益于降低 COPD 急性加重风险

近期,一项由瑞士Baumeler L等人开展的研究显示,PPI治疗对降低稳定期COPD急性加重发生风险无益,患者依然处于急性加重高风险之中。
BJS:局部进展期直肠癌治疗的研究进展

2015.11.26 BJS:局部进展期直肠癌治疗的研究进展

来自英国Mount Vernon医院癌症治疗中心l两位学者就当前LARC治疗的临床研究进展作出总结讨论,侧重于化疗方面,并指出未来研究方向。
产品特色描述

2015.09.21 产品特色描述

1. 免调码:插条即用2. 5 秒出值:快速出值 3. 自动退条:监测卫生更安全 4. 采血量 0.8μl:微量采血,几乎无痛 5.血糖读数 500 ...
上一页 1 2 3 ... 38 39 40 ... 48 49 50 下一页 到第